Profit

BSE Code: | NSE Code: | ISIN: | Sector:

NSE
663.70
Change Change %
-1.20 -0.18%

Updated:18 Sep, 2018, 15:53 PM IST

BSE
662.25
Change Change %
-0.75 -0.11%

Updated:18 Sep, 2018, 16:01 PM IST

Research Report Detail

Brokerage
Analyst
Report Date Call Price@Call Target Price
Stop Loss
Current Status Time Horizon
Nirmal Bang
N/A
26-12-2016 Buy 563.85 700.00
N/A
Closed Long (1Y)
26-12-2017

Nirmal Bang recommends buy on Cipla

Cipla has received regulatory nod for launching Sereflo salmeterol/fluticasone MDI inhaler in the UK, which is generic equivalent of GlaxoSmithKline's (GSK's) Seretide evohaler, Nirmal Bang said. With the approval for Seroflo, there will be three players in the salmeterol/fluticasone MDI space in the UK, it added.

Top